Clinical features and practical diagnosis of bullous pemphigoid
- PMID: 21605808
- DOI: 10.1016/j.det.2011.03.010
Clinical features and practical diagnosis of bullous pemphigoid
Abstract
Bullous pemphigoid (BP) represents the most common autoimmune subepidermal blistering disease. BP typically affects the elderly and is associated with significant morbidity. It has usually a chronic course with spontaneous exacerbations. The cutaneous manifestations of BP can be extremely protean. While diagnosis of BP in the bullous stage is straightforward, in the non-bullous stage or in atypical variants of BP signs and symptoms are frequently non-specific with eg, only itchy excoriated, eczematous, papular and/or urticarial lesions that may persist for several weeks or months. Diagnosis of BP critically relies on immunopathologic examinations including direct immunofluorescence microscopy and detection of serum autoantibodies by indirect immunofluorescence microscopy or BP180-ELISA.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Clinical features and practical diagnosis of bullous pemphigoid.Immunol Allergy Clin North Am. 2012 May;32(2):217-32, v. doi: 10.1016/j.iac.2012.04.002. Epub 2012 Apr 17. Immunol Allergy Clin North Am. 2012. PMID: 22560135
-
Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.Br J Dermatol. 2011 Nov;165(5):1133-7. doi: 10.1111/j.1365-2133.2011.10481.x. Br J Dermatol. 2011. PMID: 21711326
-
Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment.Am J Clin Dermatol. 2017 Aug;18(4):513-528. doi: 10.1007/s40257-017-0264-2. Am J Clin Dermatol. 2017. PMID: 28247089 Review.
-
Evaluation of a BP180-NC16a enzyme-linked immunosorbent assay in the initial diagnosis of bullous pemphigoid.Br J Dermatol. 2004 Jul;151(1):126-31. doi: 10.1111/j.1365-2133.2004.06082.x. Br J Dermatol. 2004. PMID: 15270881
-
Anti-p200 pemphigoid: a novel autoimmune subepidermal blistering disease.J Dermatol. 2007 Jan;34(1):1-8. doi: 10.1111/j.1346-8138.2007.00208.x. J Dermatol. 2007. PMID: 17204094 Review.
Cited by
-
Omalizumab and Dupilumab for the Treatment of Bullous Pemphigoid: A Systematic Review.J Clin Med. 2024 Aug 16;13(16):4844. doi: 10.3390/jcm13164844. J Clin Med. 2024. PMID: 39200987 Free PMC article. Review.
-
State-of-the-art diagnosis of autoimmune blistering diseases.Front Immunol. 2024 Jun 6;15:1363032. doi: 10.3389/fimmu.2024.1363032. eCollection 2024. Front Immunol. 2024. PMID: 38903493 Free PMC article. Review.
-
Retrospective analysis of autoimmune bullous diseases in Middle Franconia.Front Immunol. 2023 Oct 10;14:1256617. doi: 10.3389/fimmu.2023.1256617. eCollection 2023. Front Immunol. 2023. PMID: 37881435 Free PMC article.
-
Urticaria and mimickers of urticaria.Front Allergy. 2023 Sep 28;4:1274031. doi: 10.3389/falgy.2023.1274031. eCollection 2023. Front Allergy. 2023. PMID: 37841054 Free PMC article. Review.
-
Biological treatment for bullous pemphigoid.Front Immunol. 2023 Apr 27;14:1157250. doi: 10.3389/fimmu.2023.1157250. eCollection 2023. Front Immunol. 2023. PMID: 37180101 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
